Calgary, Canada

David C Schriemer


Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 110(Granted Patents)


Location History:

  • Edmonton, CA (2000 - 2003)
  • Calgary, CA (2002 - 2004)

Company Filing History:


Years Active: 2000-2004

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Mind of David C. Schriemer

Introduction

David C. Schriemer, based in Calgary, Canada, is a notable inventor with an impressive portfolio of 14 patents. His work primarily focuses on advancements in the field of screening compound libraries, which plays a pivotal role in drug discovery and development. Schriemer's innovations have significantly contributed to the methodologies and technologies used within the biotechnological industry.

Latest Patents

Among his recent innovations, Schriemer has developed an "Apparatus for Screening Compound Libraries" which integrates frontal chromatography with mass spectrometry. This cutting-edge apparatus allows researchers to identify and rank compounds that bind to target receptors, effectively facilitating the rapid screening of compound libraries to assess their affinity for specific targets. Additionally, he has patented methods for screening compound libraries that also utilize frontal chromatography along with mass spectrometry. These methods enable the quick assessment of compound libraries for their interactions with target receptors, measured by pre-selected indicator compounds.

Career Highlights

Throughout his career, Schriemer has made significant contributions while working for specialized companies, most notably Synsorb Biotech, Inc. His focus has remained on harnessing innovative technologies to advance the medical and biopharmaceutical fields, thereby improving the processes involved in drug discovery.

Collaborations

David C. Schriemer has collaborated with esteemed professionals in his field, including Ole Hindsgaul. Their partnership has fostered a creative environment for innovation and has led to various advancements in the understanding and application of screening technologies.

Conclusion

David C. Schriemer stands out as a key figure in the world of biotechnology, owing to his significant contributions in the form of patents and collaborative efforts. His innovative approaches continue to inspire progress in the industry, reflecting his commitment to improving methods of screening compound libraries for potential therapeutic applications. Schriemer’s work exemplifies how inventors can drive change and enhance the future of drug discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…